The effects of modafinil on mood and cognition in Huntington’s disease
- 1 June 2008
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 199 (1) , 29-36
Abstract
The wake-promoting agent modafinil selectively improves neuropsychological task performance in healthy volunteers, in adults with attention deficit hyperactivity disorder (ADHD) and in schizophrenia. We examined whether modafinil induced similar effects in individuals with Huntington’s disease (HD).Keywords
This publication has 39 references indexed in Scilit:
- Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measuresMovement Disorders, 2006
- Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's DiseaseJournal of Neuroscience, 2005
- Orexin loss in Huntington's diseaseHuman Molecular Genetics, 2004
- Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic SchizophreniaNeuropsychopharmacology, 2004
- Narcolepsy in orexin Knockout MiceCell, 1999
- Evidence for specific cognitive deficits in preclinical Huntington's diseaseBrain, 1998
- Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in manNeuropsychologia, 1995
- Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunctionNeuropsychologia, 1989
- Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality and Social Psychology, 1988
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986